KRAS and familial pancreatic carcinoma: On the other hand, oncogenic Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation in pancreatic cancer might promote mitochondrial division and activation of DRP1, which are essential to KRAS-driven cancer progression [55, 56].